Seaport, Hemab launch US IPOs as biotech listings gather momentum
April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings on Monday, seeking to capitalize on a growing investor appetite for new listings. The U.S. 
